Jeffrey H. Murray

Array ( [id] => 6494579 [patent_doc_number] => 20100093757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'THERAPEUTIC AGENTS 414' [patent_app_type] => utility [patent_app_number] => 12/535293 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 129167 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093757.pdf [firstpage_image] =>[orig_patent_app_number] => 12535293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478765 [patent_doc_number] => 20100041681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => '2-AMINO PYRIMIDINE COMPOUNDS AS POTENT HSP-90 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/535468 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26489 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041681.pdf [firstpage_image] =>[orig_patent_app_number] => 12535468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356093 [patent_doc_number] => 20100022537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'I-PHENY 1-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVES AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/509936 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12929 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022537.pdf [firstpage_image] =>[orig_patent_app_number] => 12509936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6528615 [patent_doc_number] => 20100015141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => '4-PHENOXY-6-ARYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE AND N-ARYL-6-ARYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES' [patent_app_type] => utility [patent_app_number] => 12/506291 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23445 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015141.pdf [firstpage_image] =>[orig_patent_app_number] => 12506291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545383 [patent_doc_number] => 20100016302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Inhibitors of bruton\'s tyrosine kinase' [patent_app_type] => utility [patent_app_number] => 12/460387 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22695 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016302.pdf [firstpage_image] =>[orig_patent_app_number] => 12460387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545911 [patent_doc_number] => 20100016330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Novel Derivatives' [patent_app_type] => utility [patent_app_number] => 12/503135 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17795 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016330.pdf [firstpage_image] =>[orig_patent_app_number] => 12503135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273616 [patent_doc_number] => 08637549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Pyridons as PDK1 inhibitors' [patent_app_type] => utility [patent_app_number] => 13/054245 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28531 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003253 [patent_doc_number] => 20110118286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'BICYCLIC HETEROCYCLE DERIVATIVES AND THEIR USE AS GPCR MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/054347 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23476 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118286.pdf [firstpage_image] =>[orig_patent_app_number] => 13054347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591451 [patent_doc_number] => 20100130515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Polymorphs and solvates of a pharmaceutical and method of making' [patent_app_type] => utility [patent_app_number] => 12/458436 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9731 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130515.pdf [firstpage_image] =>[orig_patent_app_number] => 12458436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533409 [patent_doc_number] => 08309562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Compounds and therapeutical use thereof' [patent_app_type] => utility [patent_app_number] => 12/500863 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 121129 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12500863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177895 [patent_doc_number] => 20110178106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => '5-QUINOLINONE AND IMIDAZOPYRIDINE COMPOUNDS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/002942 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6174 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178106.pdf [firstpage_image] =>[orig_patent_app_number] => 13002942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485835 [patent_doc_number] => 20090275600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'MODIFIED PYRIMIDINE GLUCOCORTICOID RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/499753 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17305 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275600.pdf [firstpage_image] =>[orig_patent_app_number] => 12499753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631789 [patent_doc_number] => 20100004449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'CRYSTALLINE FORMS OF ERLOTINIB BASE AND ERLOTINIB HCL' [patent_app_type] => utility [patent_app_number] => 12/498543 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5684 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004449.pdf [firstpage_image] =>[orig_patent_app_number] => 12498543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478713 [patent_doc_number] => 20100041677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE' [patent_app_type] => utility [patent_app_number] => 12/499002 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 42767 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041677.pdf [firstpage_image] =>[orig_patent_app_number] => 12499002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682247 [patent_doc_number] => 20100022561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE' [patent_app_type] => utility [patent_app_number] => 12/499008 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 42766 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022561.pdf [firstpage_image] =>[orig_patent_app_number] => 12499008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629422 [patent_doc_number] => 08008309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Inhibitors of bruton\'s tyrosine kinase' [patent_app_type] => utility [patent_app_number] => 12/499005 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 42827 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008309.pdf [firstpage_image] =>[orig_patent_app_number] => 12499005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784738 [patent_doc_number] => 08431581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Imidazopyrimidines and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/734042 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35846 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12734042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127925 [patent_doc_number] => 20110086859 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2011-04-14 [patent_title] => 'ALKYL SUBSTITUTED INDOLOQUINOXALINES' [patent_app_type] => utility [patent_app_number] => 12/496261 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5047 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0086/20110086859.pdf [firstpage_image] =>[orig_patent_app_number] => 12496261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026605 [patent_doc_number] => 08536187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => '2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections' [patent_app_type] => utility [patent_app_number] => 12/996110 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 50167 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12996110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127925 [patent_doc_number] => 20110086859 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2011-04-14 [patent_title] => 'ALKYL SUBSTITUTED INDOLOQUINOXALINES' [patent_app_type] => utility [patent_app_number] => 12/496261 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5047 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0086/20110086859.pdf [firstpage_image] =>[orig_patent_app_number] => 12496261 [rel_patent_id] =>[rel_patent_doc_number] =>)